Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Filings indexed 1,119 across all filing types
Latest filing 2013-03-27 Capital/Financing Update
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
SPP Letter to Option Holders 1 page 265.5KB
Capital/Financing Update Classification · 95% confidence The document is a letter dated 28 March 2013 from the Managing Director and CEO of Invion Limited announcing a Share Purchase Plan (SPP) for eligible shareholders. It explains the terms of the SPP, eligibility criteria, and contact information for queries. The document is short (1332 characters) and serves as an announcement of a capital raising opportunity through a share purchase plan. It does not contain financial statements, detailed financial data, or management discussion. It is not a full report but an update on financing activity related to share issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2013-03-27 English
SPP Letter to Shareholders and Plan Rules 17 pages 942.4KB
Capital/Financing Update Classification · 95% confidence The document is a detailed letter and offer to shareholders regarding a Share Purchase Plan (SPP) by Invion Limited. It includes terms and conditions of the plan, the purpose of the capital raise, key dates, and instructions for participation. The content focuses on inviting shareholders to purchase additional shares at a discount, describing the use of proceeds, and providing background on the company's clinical trials and market opportunities. There is no financial statement or quarterly/annual report data, no earnings highlights, no management discussion of financial results, no regulatory certification, and no voting or governance information. The document is clearly an announcement and offer related to a capital raising activity through a share issue. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2013-03-27 English
Appendix 3B 13 pages 715.8KB
Share Issue/Capital Change Classification · 100% confidence The document is an ASX announcement titled 'Appendix 3B New issue announcement' dated 28 February 2013. It details the release of securities from escrow, the number and class of securities issued, and compliance with ASX listing rules, including placement capacity calculations under rule 7.1 and 7.1A. Appendix 3B is a standard form used in Australian securities markets to announce new issues of securities and applications for quotation of additional securities. The document is not a financial report, earnings release, or management discussion but a regulatory announcement about capital changes and securities issuance. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is substantial and contains detailed information about securities issuance, confirming it is not merely a brief announcement or a report publication notice.
2013-02-27 English
Corporate Presentation 19 pages 1.6MB
Investor Presentation Classification · 95% confidence The document is titled as an "Updated Corporate Presentation" and contains detailed information about the company's drug development pipeline, management team, market opportunities, and clinical trial plans. It is structured as a presentation with sections on the company's products, development strategy, market size, and leadership. There are no financial statements, regulatory filings, or voting results. The document is clearly intended for investors and the market to provide an overview of the company's strategy and prospects. This matches the definition of an Investor Presentation (IP). The document length is substantial (over 14,000 characters), indicating it is the full presentation, not just an announcement or summary. Therefore, the appropriate classification is Investor Presentation (IP).
2013-02-24 English
Appendix 4D and Half-year Financial Report 24 pages 711.1KB
Regulatory Filings
2013-02-18 English
Appendix 3B 7 pages 297.8KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B' and is an announcement related to the issue of new securities, specifically unlisted share options, by Invion Limited. It includes details such as the class of securities, number issued, exercise price, expiry date, and purpose of the issue (ESOP to consultants). The document also contains information about the quotation application for these securities on the ASX (Australian Securities Exchange). This type of document is a formal announcement of a capital raising or share issue event, not a full financial report or earnings release. It fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The document length (10,377 characters) and detailed content confirm it is not a mere announcement of a report or a certification. Therefore, the correct classification is CAP with high confidence.
2013-02-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.